
北美心血管设备市场预测至 2028 年 - COVID-19 影响和区域分析(按设备 [心电图 (ECG)、起搏器、支架、除颤器、心导管、导丝、心脏瓣膜、事件监测器等]、应用(冠心病) 、心脏骤停、中风、脑血管心脏病等)和最终用户(医院、门诊手术中心和心脏中心)
No. of Pages: 164 | Report Code: TIPRE00005824 | Category: Life Sciences
No. of Pages: 164 | Report Code: TIPRE00005824 | Category: Life Sciences
在过去十年中,世界见证了心血管设备的显着发展,为医生提供了帮助以及采用新方法治疗房性心律失常、室性心律失常和室性心房颤动等疾病的患者。心律失常和其他心血管疾病 (CVD) 的日益流行鼓励了改进的心血管设备的引入。据世界卫生组织 (WHO) 统计,每年约有 3000 万人遭受中风。美国心脏协会指出,美国约 50% 的成年人患有某种心血管疾病。此外,预计到 2035 年,将有超过 1.3 亿人(即美国人口的 45.1%)患有某种心血管疾病。根据美国心脏协会 (AHA) 2019 年的统计数据,美国有 1.215 亿成年人,即大约一半的美国成年人患有心血管疾病。北美心血管设备市场预计在预测期内将以良好的复合年增长率增长。
< /p>
北美心血管器械市场细分
北美心血管设备市场分为设备、应用程序、最终用户和国家/地区。根据设备,市场分为心电图(ECG)、起搏器、支架、除颤器、心导管、导丝、心脏瓣膜、事件监视器等。 2020年,事件监测器领域在北美心血管设备市场占据主导地位。根据应用,该市场分为冠心病、心脏骤停、中风、脑血管心脏病等。冠心病细分市场在 2020 年占据主导地位。根据最终用户,市场分为医院、门诊手术中心和心脏中心。医院细分市场在 2020 年占据主导地位。根据国家/地区,北美心血管设备市场分为美国、墨西哥和加拿大。 2020年,美国在北美心血管器械市场占据主导地位。
美敦力、波士顿科学公司、雅培、强生服务公司、通用电气公司、皇家飞利浦 NV、西门子 Healthineers AG、BD、B. Braun Melsungen AG、和 Edwards Lifesciences Corporation 是北美心血管设备市场的领先公司之一。
Strategic insights for North America Cardiovascular Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 19,680.36 Million |
Market Size by 2028 | US$ 30,779.03 Million |
Global CAGR (2021 - 2028) | 6.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 设备
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Cardiovascular Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Cardiovascular Devices Market is valued at US$ 19,680.36 Million in 2021, it is projected to reach US$ 30,779.03 Million by 2028.
As per our report North America Cardiovascular Devices Market, the market size is valued at US$ 19,680.36 Million in 2021, projecting it to reach US$ 30,779.03 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The North America Cardiovascular Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cardiovascular Devices Market report:
The North America Cardiovascular Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cardiovascular Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cardiovascular Devices Market value chain can benefit from the information contained in a comprehensive market report.